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ABSTRACT 
Transcription Activator-Like Effectors (TALEs) Hybrid Nucleases for Genome 
Engineering Application 
 
Gene targeting is a powerful genome engineering tool that can be used for a 
variety of biotechnological applications. Genomic double-strand DNA breaks 
generated by engineered site-specific nucleases can stimulate gene targeting. 
Hybrid nucleases are composed of DNA binding module and DNA cleavage 
module. Zinc Finger Nucleases were used to generate double-strand DNA 
breaks but it suffers from failures and lack of reproducibility.   The transcription 
activator–like effectors (TALEs) from plant pathogenic Xanthomonas contain a 
unique type of DNA-binding domain that bind specific DNA targets. The purpose 
of this study is to generate novel sequence specific nucleases by fusing a de 
novo engineered Hax3 TALE-based DNA binding domain to a FokI cleavage 
domain. Our data show that the de novo engineered TALE nuclease can bind to 
its target sequence and create double-strand DNA breaks in vitro. We also show 
that the de novo engineered TALE nuclease is capable of generating double-
strand DNA breaks in its target sequence in vivo, when transiently expressed in 
Nicotiana benthamiana leaves. In conclusion, our data demonstrate that TALE-
based hybrid nucleases can be tailored to bind a user-selected DNA sequence 
and generate site-specific genomic double-strand DNA breaks. TALE-based 
hybrid nucleases hold much promise as powerful molecular tools for gene 
targeting applications. 
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I. INTRODUCTION 
 
For centuries, humans have made efforts to secure the food supply by selecting 
crop varieties of higher yield and resistance to pathogens and stress cues. These 
selection methods have developed over time to include genetics based breeding 
programs and genetic engineering. In 1970s, the advent of restriction enzymes 
has marked the beginning of the genetic engineering where scientists were able 
to cut and ligate pieces of DNA. In 1980s, scientists were able for the first time to 
transform plants with foreign genes, ushering in an exciting field of plant genetic 
engineering. Genetic engineering technology allows us to directly manipulate the 
genome of an organism without going through breeding and random 
mutagenesis. Genetic engineering, however, suffers from two major drawbacks, 
the insertion of the gene of interest into the genome is random and the inserted 
gene could affect other endogenous genes resulting in unwanted effects (Gepts, 
2002; Jauhar, 2001; Wang et al., 2009; Zhong, 2001). 
 
In the last decade, researchers have begun to develop the next generation 
technology called “genome engineering”. This technology allows a highly 
efficient, targeted and precise modification of the genome of an organism. The 
application of this technology would allow a robust and efficient addition, deletion, 
activation and inactivation of genes with high precision and specificity. The ability 
to manipulate the genome in such ways would accelerate the trait development 
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process and expand the range of traits and plant species amenable to genetic 
modification (Durai, 2005; Wirth et al., 2007). 
 
Genome engineering tools include chimeric proteins that are usually composed 
of a DNA binding module and an effectors domain with the ability to activate or 
repress transcription and cleave or modify the DNA of the target gene (Collins, 
2003; Urnov et al., 2010). The type IIs restriction endonuclease FokI isolated 
from Flavobacterium okeanokoites is arranged in a modular structure consisting 
of N-terminal DNA recognition domain and a C-terminal non-specific DNA 
cleavage domain (Durai et al., 2005). DNA cleavage by FokI requires the 
dimerization of FokI and the occurrence of magnesium ions. When FokI 
recognition domain bound to duplex DNA at non-palindromic recognition 
sequence 5′-GGATG-3:5'-CATCC-3', DNA cleavage domain will be activated and 
cleave DNA non-specifically at 9 bp and13 bp downstream of the recognition site 
(Bitinaite et al., 1998; Wah et al., 1998). The modular nature of FokI has made it 
an ideal candidate for the construction of hybrid endonucleases with novel 
sequence specificities, by combining cleavage domain of FokI to variety of DNA-
binding domains that could recognize longer DNA sequences such as the zinc 
fingers or TALEs (Gersbach et al., 2010; Gordley et al., 2007).  
 
Zinc-finger nucleases (ZFNs) are artificial hybrid proteins generated by fusing a 
zinc finger DNA-binding domain to a DNA-cleavage domain of FokI 
endonuclease (Pabo et al., 2001; Vanamee et al., 2007). Zinc finger modules can 
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be engineered to recognize a particular DNA sequence both in vitro and in vivo 
which enables ZFN to induce Double-stranded breaks (DSBs) at specific 
genomic locus (Cathomen and Joung, 2008; Kim et al., 1996). DSB at a specific 
genomic locus can be subsequently repaired by the NHEJ (Non-Homologous 
End Joining) pathway. Imprecise repair by NHEJ leads to occasional loss or gain 
of the genetic information in form of small insertions or deletions, which could 
disrupt the gene function (Ramalingam et al., 2010; Wang et al., 2003). Zinc 
Finger Nucleases (ZFNs) have been used to manipulate the genome of various 
organisms, including zebra fish (Doyon et al., 2008; Thermes et al., 2002), yeast 
(Epinat et al., 2003; Li et al., 2011), plants (Chiurazzi et al., 1996; Lloyd, 2005), 
and mammals (Epinat et al., 2003; Miller et al., 2010). However, the process of 
designing and creating sequence-specific DNA-binding proteins which are based 
on zinc fingers remains labor intensive, difficult, expensive and less reproducible 
(Miller et al., 2010; Ramirez et al., 2008). There is a pressing need for a DNA 
binding module with extreme specificity that can be adaptable for any user 
selected target sequence. Recently, scientists developed sequence-specific 
DNA-binding proteins based on transcription activator-like effectors (TALE) of the 
pathogen plant Xanthomonas sp. 
 
Phytopathogenic bacteria of the genus Xanthomonas inject TALE via the type III 
secretion system. TALE- related proteins are also found in Ralstonia 
solanacearum (Heuer et al., 2007; Yang and White, 2004). These TALEs act as 
virulence factors, translocated to the nucleus and function as transcription factors 
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by binding to their DNA target in the promoter region and reprogram the gene 
expression of the host (Boch and Bonas, 2010; Gürlebeck et al., 2006). The 
avrBs3 gene from the pepper and tomato pathogen Xanthomonas campestris pv. 
vesicatoria was the first TALE to be isolated and identified (Minsavage et al., 
1990). The most distinct structural feature of TALE is the presence of the tandem 
repeat central domain. The number of repeats varies from one TALE to another 
but they range from 1.5 to 33.5 repeats (Boch and Bonas, 2010). The repeat 
central domain of the avrBs3 gene consists of 17.5 of 102-bp long DNA repeats, 
each repeat encodes 34 amino acids (Bonas et al., 1989). After the discovery of 
the avrBs3 gene, some homologous genes including avrXa5, avrXa7, and 
avrXa10 were isolated and identified from the rice pathogen Xanthomonas 
oryzae pv. Oryzae. These three proteins exhibit the same structural features of 
avrBs3, they have central domain tandem repeats similar to that of avrBs3, albeit 
with varied number, length, and arrangement of repeats. Structural comparison 
between AvrBs3 and AvrXa10 first showed that the polymorphism between TALE 
central domain repeats occurs in the amino acid number 12 and 13 of each 
repeat, known as the repeat variable diresidue (RVD) (Hopkins et al., 1992). The 
target of the AvrBs3 in plants was identified in pepper and referred to as UPA 
(upregulated by AvrBs3) (Marois et al., 2002). UPA box, a highly conserved 
promoter region was found in some UPA genes, and several studies showed that 
AvrBs3 may directly bind to the UPA box. AvrBs3 can bind specifically to target 
sequences, both in-vitro and in-vivo (Kay et al., 2007; Kay et al., 2009).  
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Since the discovery of AvrBs3 family of TALEs, several studies have focused on 
the contribution of the tandem repeats of the central domain to dictate the 
specificity of TALEs to the DNA binding box in the promoter region of the target 
gene. Two major studies employing experimental and bioinformatics methods 
deciphered the code of TALE binding to the DNA target. These two studies 
observed that the length of the UPA box is more or less similar to the number of 
AvrBs3 central tandem repeats. This observation led to testing the hypothesis 
that each repeat binds to one nucleotide in the DNA target sequence (Boch et al., 
2009; Moscou and Bogdanove, 2009).  
 
Moscou and Bogdanove showed that the association between various RVDs of 
TALEs and DNA nucleotides of the target sequence does not occur at random. 
Based on the association of 382 RVD–nucleotide studied, they observed that 
histidine and aspartic acid (HD) is the most common RVD to be found and is 
strongly associated with nucleotide C. Other most common RVDs are 
asparagines and glycine (NG), which is associated with nucleotide T, and 
asparagine and isoleucine (NI) which is associated with nucleotide A. Two 
asparagines (NN) is the next most frequent RVD to be found and is associated 
with nucleotide G, but is also found to associated with nucleotide A. Other RVDs 
also frequently found are asparagine and serine (NS) which was found to be 
associated with G, A, or C, and the last one is histidine and glycine (HG) of which 
association resembles that of NG. Several other RVDs were also found, but with 
very rare occurrence (Fig. 1)(Moscou and Bogdanove, 2009). 
14 
 
 
 
 
 
 
 
 
Fig. 1. TALE - DNA recognition code. Letter size represents association 
frequency between each nucleotide to particular RVD (Moscou and Bogdanove, 
2009). 
 
Association between various RVDs of TALE with DNA nucleotides of the target 
sequence was also proved experimentally. Boch et al. deciphered the TALE code 
by comparing RVDs of AvrBs3 to UPA box sequence, in which they observed 
that UPA box has the base pair length similar to the number of repeats in AvrBs3 
central domain. Based on this observation, they predicted the target sequences 
for Hax2, Hax3, and Hax4 from X. campestris pv. Armoraciae and generate 
artificial promoters that match these three TALEs. Using transient expression 
assay they demonstrated that artificial promoters containing target sequence for 
Hax2, Hax3, or Hax4 were only induced by the specific corresponding effector. 
Further, to showed that each RVD are recognize specific base pair, they 
permutated the Hax4 target sequence (Hax4 box). GUS assay demonstrated that 
permutation of nucleotides A, T, or C on Hax4 box which corresponds to RVDs 
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NI, NG, and HD respectively, abolished the GUS activity, whereas for NS, 
permutations had not effect. In addition, they constructed ArtX1, an artificial 
TALE which include RVD NN. Permutations on ArtX1 box demonstrated that NN 
corresponds with A or G. These experiments verified the correspondence 
between each RVD and a DNA nucleotide of the target, where HD corresponds 
to nucleotide C; NG corresponds to nucleotide T; NI corresponds to nucleotide A; 
NS corresponds to nucleotides A, C, or G; and NN corresponds to nucleotide A 
or G. They also concluded that the conserved T preceding the DNA target box 
was crucial for binding and might interact with repeat 0, an unidentified repeat 
(Boch et al., 2009). In a recent study, Morbitzer et al. added that RVD 
asparagines and lysine (NK) mediates specific interaction with nucleotide G 
(Morbitzer et al., 2010). Overall, the experimental evidence from Boch et al. and 
the bioinformatic evidence from Moscou and Bogdanove have resulted in 
deciphering the TALE-DNA binding code.  
 
The main constraint of the use of the DNA binding domain of TALE is the 
difficulty of constructing novel TALEs routinely because the DNA binding domain 
of TALE consists of a large number of  nearly identical tandem-arranged repeats. 
This highly homologous repetitive structure might lead to plasmid instability 
during cloning rendering the process of constructing customized TALEs relatively 
difficult. Gene synthesis of TALEs with novel repeat specificity is possible but 
relatively expensive and time consuming (Cermak et al., 2011; Li et al., 2011; 
Morbitzer et al., 2011; Zhang, 2011). 
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Recently several groups have reported the construction of novel TALEs with 
customized specificity. Usually the construction of new TALEs stars with codon 
optimization to facilitate their expression in specific organism. Miler et al. reported 
the construction of customized TALE that can recognize the human endogenous 
genes CCR5 and NTF3 using infusion cloning of several overlapping repeats 
fragments (Miller et al., 2010). While Zhang et al. developed a hierarchical 
ligation-based method to overcome the difficulty of TALEs construction with 
tandem repeat domains. They used a method similar to the Golden Gate cloning 
for multiple DNA fragment ligation. In order to assemble each individual repeats 
monomer in a specific order, they modified the DNA sequence at the junction 
between each pair of repeat monomer. Using a variety of different codons, at 
each junction they designed unique 4-bp sticky-end ligation adapters. Using this 
method, four repeat monomers can be assembled directly into 4-mer 
intermediary arrays. Three 4-mer intermediary arrays can be combined directly to 
produce a 12-mer intermediary arrays which then ligated to a backbone vector to 
produce a full-length TALE with 12 RVDs (Fig 2.)(Zhang, 2011). Cermak et al. 
applied the similar system, they reported that the construction process of a novel 
TALE can be done within 5 days, consisting of 2 stages: (1) constructing several 
repeat monomers into intermediary arrays which consist of 1-10 repeats and (2) 
combining intermediary arrays with a backbone vector to produce a full-length 
TALE (Cermak et al., 2011).  
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Fig. 2. Assembly of a customized TALEs in serial ligations with type IIs 
restriction endonuclease. Type IIS restriction endonucleases can cut DNA 
outside of its recognition site, producing unique 4-bp sticky-end overhangs. The 
cloning process can be accelerated because the digesting and ligating processes 
are performed in a single reaction because the appropriate assembly of repeat 
monomers will eliminate the enzyme recognition site (Zhang, 2011). 
 
The protocols developed by Cermak et al. and Zhang et al. involves several 
times of amplifications and ligations to construct each individual repeat. Morbitzer 
et al. developed less laborious protocols by combining a modular assembly 
based method with Golden Gate cloning method that allows the construction of 
18 
 
TALEs from multiple repeats fragments by using type IIs restriction enzymes in 
two sequential cut-ligation reactions. Using the method, each individual repeat of 
monomer can be constructed specifically to assemble functional repeat arrays 
that can recognize user-predefined target sequence (Morbitzer et al., 2011).  
 
Similarly, Li et al. and Weber et al. also reported the development of modular 
assembly-based construction method. Li et al. used four repeats monomers with 
RVD NI, NG, NN and HD to create 48 ready-to-use modules that can be 
constructed into functional repeat arrays with varying number of repeat units up 
to a maximum of 23 repeats. The construction of each repeat module can be 
performed in a controlled order, based on a specific DNA target sequence that 
the user desired (Li et al., 2011). Weber et al. developed a strategy to construct 
novel TALEs using 17.5 repeat-containing AvrBs3 TALE as a scaffold. They 
create 68 ready-to-use repeat modules, where DNA binding domain for any 17 
base pair target sequence of user choice can be constructed by assembling 
selected modules in two cloning steps using the Golden Gate cloning method 
that allows directional and continuous assembly of multiple DNA fragment. The 
modular assembly-based methods above are quite simple, fast, and inexpensive 
and in the future will allow high-throughput TALEs synthesis (Weber et al., 2011). 
 
DNA binding domain of TALE and its simple correspondence with a base DNA 
target opens an array of potential biotechnologies applications. Several studies 
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have reported the success of designing custom TALEs that can recognize 
specific DNA sequences and regulate the transcription of diverse endogenous 
genes of the target genome in various cell types including yeast, plants and 
mammals (Miller et al., 2010; Morbitzer et al., 2010; Zhang, 2011). TALEs can be 
combined with various effectors domain, akin to ZFNs, we can create a 
transcription activator-like effector nucleases by combining the DNA binding 
domain of TALE with a non-specific cleavage domain from the type II restriction 
endonuclease FokI. Recently, Cermak et al. demonstrated the success of the 
use of novel customized TALE for inducing DSB and mutagenesis of the ADH1 
gene in Arabidopsis protoplast. They show that a custom TALE can create DSB 
on the recognition site and lead to mutation in the form of 4-15 bp deletions at the 
spacer locus. This mutation is attributable to the imprecise repair of the cleaved 
chromosomes by NHEJ process (Cermak et al., 2011). 
 
In mammalian system, Miller et al. demonstrated the use of TALE in activating 
and modifying endogenous genes in cultured human cells. The natural 13-
repeats TALE protein was replaced with 18 repeats designed to recognize 18-bp 
section of the promoter region of the endogenous human gene NTF3 
(neurotrophin-3). The 18 repeat TALE proteins were combined with a 
transcriptional activator, VP16. They demonstrated that the hybrid protein can 
activate the transcription of NTF3 and increase NTF3 expression level up to 
twentyfold. Then, the VP16 domain was replaced with FokI nuclease. Similar to 
various other studies on yeast and Arabidopsis, the hybrid nuclease protein is 
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able to induced DSB at specific target sequence on the human genes NTF3 and 
CCR5, which followed by NHEJ-mediated genome modification in the form of 
small deletions. They observed that up to 9% of the treated cells carried 
mutations, when the NTF3 gene was targeted by a custom TALE nuclease. On 
the CCR5 gene, more than 20% mutated alleles of CCR5 gene were observed.  
In addition, Miller et al. also demonstrated the use of TALE for gene editing 
through homology directed repair (HDR). Custom TALE nucleases and donor 
DNA fragments constructed to transfer 46-bp were inserted to K562 cells. They 
succeeded in showing an efficient and precise editing, in which 16% of alleles 
having the expected insertion (Miller et al., 2010).  
 
Because of the relatively simple structure of the DNA-binding domain of TALE 
and the potential of using TALE to identify long DNA sequences, engineered 
TALE can be generated reproducibly and can overcome the limitations of and 
ZFN technologies. Engineered TALE may significantly advance the genome 
modification technologies and be a powerful tool for agricultural biotechnology or 
gene therapy. Here we reported the generation of novel sequence specific 
nucleases by fusing engineered Hax3 TALE-based DNA binding domain to a 
FokI cleavage domain. We showed that our de novo engineered TALE nuclease 
can bind to its target and create DSB in vitro. We also showed its ability to create 
a DSB in its target sequence in vivo, when transiently expressed in N. 
benthamiana leaves. 
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II. MATERIAL AND METHODS  
dHax3 TALE Assembly and Vector Construction 
Optimization of Hax3 cDNA is performed to reduce the homology of central 
repeats and to decrease the value of GC content. dHax3 and dHax3.N cDNAs 
used in this study was synthesized by the Bio BlueHeron in a pUC19 vector. The 
cDNAs were amplified and cloned in the pENTR/D vector to produce 
pENTR/dHax3 and pENTR/dHax3.N gateway entry clones. The resulting clones 
were confirmed by sequencing (Appendix 1). LR recombination was performed 
between the entry clones and the gateway-compatible pET32a expression 
vector, to produce pET32a.dHax3 and pET32a.dHax3, as described in the 
instruction manual from the manufacturer. The expression clones were 
transformed into Escherichia coli BL21. The protein expression was induced by 
adding β-D-1thiogalactopyranoside (IPTG) in the culture medium and incubating 
the E. coli culture at 25° C for 5 hours. The His.dHax3, His.dHax3.N, TRX. 
dHax3, and TRX.dHax3.N proteins were purified using Qiagen Ni-NTA agarose 
resin, as described in the instruction manual from the manufacturer. To produce 
the overexpression clones pK2GW7/dHax3 and pK2GW7/dHax3.N, LR reactions 
were performed between the pENTR/dHax3 and pENTR/dHax3.N entry clones 
and the pK2GW7 gateway compatible binary vector. The expression clones 
produced were subsequently transformed into A. tumefaciens GV3101 for use in 
transient expression in tobacco leaves. 
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Electrophoretic mobility shift assay (EMSA)  
TRX.dHax3 and TRX.dHax3.N proteins were purified from E. coli BL21 as 
previously described. The protein concentration was measured with a protein 
assay kit (BioRad). For binding studies, 5 'biotinlabeled or nonlabeled 
oligonucleotides were annealed and used as probes. Using the Lightshift 
Chemiluminscent EMSA kit (Pierce), all of the EMSA reactions were performed 
as described in the instruction manual from the manufacturer. 12 mM Tris·HCL, 
60 mM KCl, 1 mM DTT, 2.5% glycerol, 5 mM MgCl2, 50 ng/µL poly(dI.dC), 
0.05% NonidetP-40, 0.2 mM EDTA, 35 fmol biotin-labeled DNA, 10 pmol 
unlabeled DNA, and 30–480 fmol TRX.His fusion proteins were contained in 
EMSA binding-reaction buffer. For 10 minutes, the EMSA binding reactions were 
reserved on ice before the biotin-labeled probe was added. Using 8% 
Tris/Borate/EDTA (TBE) native ready-made gels from Invitrogen, gel 
electrophoresis was conducted. Blotting was performed on a nylon membrane 
with positive charges, and then it was cross-linked using CL-1000 UV cross-
linker for 30 s. 
 
dHax.3N in vitro DNA Cleavage Analysis 
dHax.3N EBEs were cloned in a tail to tail orientation in sense and antisense 
strands, respectively. The EBEs cloning was achieved by the synthesis of the 
EBEs complementary ssDNA with 3′A overhangs to assist TA cloning. The EBE 
ssDNA was recombined and replicated into the TOPO TA cloning vector 
(Invitrogen), and the EBE clones were identified by sequencing. The 
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pCRII/EBE6, pCRII/EBE10, and pCRII/EBE16 clones were digested to 
completion by NcoI, and 500 ng linearized EBE clones were utilized in the 
digestion reactions with Trx.His.dHax.3N-purified protein. The digestion reactions 
were conducted in a buffer containing 20 mM Tris·HCl (pH 7.4), 5 mM MgCl2, 50 
mM KCl, 5% glycerol, and 0.5 mg/mL BSA. They were then incubated for 30 
minutes at 37°C and further analyzed by DNA gel electrophoresis. To study the 
effects of mutation in the DNA target on the cleavage activity dHax3.N enzyme, 
we constructed two mutant clones. First, we removed the T nucleotide that 
matches with repeat 0, and second by substituting the last T that matches with 
repeat 11.5 with A.  
 
A. tumefaciens-Mediated Transient Expression Assay in N. 
benthemiana leaves 
We used transient assays in N. benthamiana leaves, to study the activity of 
dHax3.N in vivo. The dHax3.N target was designed to include the combination of 
EBE-stop codon.spacer-EBE fused in frame to uidA cDNA and replicated in a 
binary vector to create pK2GW7 (35S:: EBE-TGA. Spacer.-EBE-GUS). The EBE-
TGA.spacer-GUS clone was created by amplifying the uidA cDNA using the 
EBE-TGA-GUS-F and GUS-R primers. The PCR product was cloned into the 
pENTR/D vector and subcloned by LR reaction in the pK2GW7 overexpression 
vector. The pK2GW7/EBE-TGA.spacer-EBE-uidA and pK2GW7/dHax3.N were 
transformed into A. tumefaciens GV3101 and co-infiltrated or infiltrated 
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separately into tobacco leaves, and the infiltrated discs were collected 48 hpi. 
The GUS qualitative assay was conducted by immersing leaf discs in GUS-
staining solution (which contains 10 mM sodium phosphate, pH 7, 10 mM EDTA, 
0.1% Triton X-100, 0.1% 5- bromo-4-chloro-3-indolyl-β-D-glucuronide, 1 mM 
potassium ferricyanide, 1 mM potassium ferrocyanide) at 37 °C for 24 h. The 
discs were cleared in ethanol. 
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III. RESULTS 
De Novo Hax3 TALE-Based Hybrid Nuclease Design and Assembly  
We selected Hax3 effector of TALEs protein family as the basis for the 
construction of our customized TALE-based nuclease, because Hax3 protein is 
relatively smaller compared to other members of TALEs family. Hax3 has 11.5 
repeats in the central DNA binding region; repeats of that size are adequate for 
specific and strong binding as well as for activating target promoter (Boch et al., 
2009)(Fig. 3A). TALE genes are usually constructed by using PCR-based 
method, and to modify the RVDs of TALE PCR mutagenesis-based method is 
generally used. The sequence of natural Hax3 cDNA (GenBank accession no. 
AY993938.1) has a relatively high overall GC content i.e. 65% and its 11.5 
tandemly arranged repeats in the central DNA binding region are almost identical 
one to another which makes PCR mutagenesis of these repeats challenging. In 
order to overcome these limitations, we created codon-optimized versions of the 
original Hax3 cDNA, herein defined to as dHax3. dHax3 are codon-optimized for 
in-planta expression, which has a GC content of only 47% and show less 
homology between the 102-bp repeats compared to the original Hax3 cDNA.  
 
Natural Hax3 TALE can attach to the target DNA with sequence 
TACACCCAAACAT (Boch et al., 2009). We modified the RVDs of the original 
Hax3, so that the dHax3 we constructed can attach to the 12-bp sequence 
TCCCTTTATCTCT in the RD29A promoter (Yamaguchi-Shinozaki and 
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Shinozaki, 1993)(Fig. 3B). It should be noted that the target sequence begins 
with nucleotide T at position 0. It was previously reported that nucleotide T at 
position 0 which found in all TALE target sites, contributes to TALE mediated 
activation of the respective promoters of target genes, and might also be crucial 
in the binding process of TALE to the target sequence.  
 
 
 
 
 
 
 
 
 
Fig. 3 . Schematics of a Hax3 and dHax3.N proteins and their DNA target 
specificity. (A)  Hax3 TALE has a central DNA binding domain with 11.5 repeats 
units (repeat domains, shown in red), in which each repeats unit consists of 34 
aa, representation of the first repeat is shown below, with RVD at position 12 and 
13 shown in green. A nuclear localization motifs (NLS) shown in yellow, and a 
transcription activation domain (AD), at the C-terminus, shown in green. (B)  
RVDs composition of the 11.5 repeat units of Hax3 and dHax3 and its 
corresponding 12-bp DNA-binding target. (C) Schematic representation of the 
dHax3.N with the FokI cleavage domain at the C-terminus of dHax3.  
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A hybrid dHax3 nuclease is constructed by fusing in frame the DNA sequence 
encoding the full-length dHax3 sequence with DNA sequence encoding 196 aa of 
the FokI C-terminal cleavage domain. The type II restriction endonuclease FokI 
was selected because several previous studies have reported non-specific 
catalytic activity of FokI when combined with other DNA-binding domains, such 
as DNA binding domain of zinc finger proteins (Mani et al., 2005). The hybrid 
dHax3 nuclease, henceforth referred to as dHax3.N, has 1,157 aa residues and 
about 124 kDa molecular mass (Fig. 3C). In the design of dHax3.N, dHax3 was 
designed to provide DNA binding specificity, while the cleavage domain of FokI is 
to provide nuclease activity. dHax3.N was synthesized in fragments which then 
fused together and cloned into a pUC19 vector and then, into a pENTR/D 
gateway vector; sequencing was used to confirmed the constructs. The dHax3 
and dHax3.N clones were then subcloned into the pET32a expression vector to 
produce thioredoxin.6His fusion proteins (Trx.His.dHax3 and Trx.His.dHax3.N). It 
was shown that the bacterially expressed Trx.6His.dHax3 and Trx.6His.dHax3.N 
proteins migrated in SDS protein gel electrophoresis to their estimated sizes 
(Appendix 2). 
 
DNA-Binding Activities of dHax3 and dHax3.N Hybrid Nucleases in 
vitro and Activation of Target Gene Expression in Vivo.  
The Trx.6his-tagged dHax3 and dHax3.N proteins were purified from E. coli and 
then tested for their DNA-binding specificity to the 12-bp EBE in vitro. The ability  
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Fig. 4. Binding specificity of dHax3 and dHax3.N to their target DNA and in vivo 
transcriptional activation. (A)  Double-stranded oligonucleotides probe used in the 
EMSA, containing dHax3 and dHax3.N EBE target sequence (shown in blue) (B)  
EMSA demonstrating specificities of dHax3 and dHax3.N binding to the EBE 
target sequence; Panel 1 thioredoxin tag can not bind to biotinlabeled probe. 
Panel 2 dHax3 protein bind to biotinlabeled probe sequence in a concentration-
dependent manner. Panel 3 unlabeled probes competitively reduced the binding 
between dHax3 protein and biotinlabeled probe (C) EMSA demonstrating 
specificities of dHax3 and dHax3.N binding to the EBE target sequence; Panel 1 
thioredoxin tag can not bind to biotinlabeled probe. Panel 2 dHax3.N protein bind 
to biotinlabeled probe sequence in a concentration-dependent manner. Panel 3 
the competition between biotinlabeled probe and unlabeled probe to bind to 
dHax3.N (D) dHax3 and dHax3.N transcriptionally activates RD29A promoter in 
vivo. Panels 1 and 2 acts as negative control, shows that the addition of dHax3 
or dHax3.N only does not trigger uidA activity. Panel 3 shows the background 
activity of RD29A promoter. Panels 4 and 5 shows the transcriptional activation 
of RD29A promoter by dHax3 and dHax3.N, respectively. Panel 6 A positive 
control of 35S::uidA.. In the three times the experiment was performed, similar 
results were achieved; each used 60 plants (10 plants per panel). 
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of purified Trx.6his-tagged dHax3 and dHax3.N to attach to the DNA target in 
vitro was tested with EMSA.  Both proteins were used in EMSA along with biotin 
labeled double-stranded oligonucleotides, containing the EBE target sequence 
(Fig. 4A). 
 
The EMSA demonstrated that Trx.6His.dHax3 and Trx.6His.dHax3.N proteins 
can attach specifically to double-stranded oligonucleotides containing their EBE 
target sequence. dHax3 and dHax3.N bindings to labeled double-stranded 
oligonucleotides competitively reduced with the addition of unlabeled double-
stranded oligonucleotides of the same sequence (Fig. 4B and C). Data from this 
study also shows that thioredoxin tag did not affect the binding of the dHax3 and 
dHax3.N proteins to the EBE target sequence.  
 
Aside from having DNA binding domain, TALEs also have C-terminal 
transcription activation domain. We have hypothesized that the combination of 
FokI C-terminal cleavage domain on the C-terminus of dHax3 will not affect the 
activation domain of dHax3 and the activation domain will remain functional. 
To investigate whether dHax3 and dHax3.N proteins can attach to target 
sequence in vivo and activate gene transcription, we subcloned dHax3 and 
dHax3.N in binary vector under control of the strong CaMV 35S promoter. The 
35S::dHax3 and 35S::dHax3.N constructs were transformed into A. tumefaciens 
and delivered by injection into N. benthamiana leaves for transient expression 
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assays. A 300-bp RD29A promoter was cloned upstream of the uidA cDNA in the 
pK2GWFS7 binary vector (Karimi et al., 2007). The 35S::dHax3 and 
35S::dHax3.N containing Agrobacteria were co-infiltrated in N. benthemiana 
leaves with Agrobacterium that contained RD29A::uidA. Leaf discs of the 
infiltrated regions were collected 24 h post-infection (hpi) and dyed with beta-
glucuronidase (GUS) staining buffer to observe the activity of the UidA reporter. 
The data demonstrated that dHax3 and dHax3.N can bid to and activate the 
RD29A promoter (Fig. 4D). 
 
DNA cleavage activities of dHax3.N Hybrid Nuclease  
Next we wanted to test our de novo engineered TALE nuclease protein ability to 
cut the target DNA sequence in vitro. We constructed plasmid containing two 
EBE target sequences in a tail-to-tail orientation separated by spacers with 
different lengths. To help the data analysis, we incorporated restriction sites for 
endonuclease SmaI in the spacer regions. We constructed three clones 
pCRII/EBE6, pCRII/EBE10, and pCRII/EBE16, each of which has a spacer 
region with 6-bp, 10-bp, and 16-bp long (Fig. 5A and B). We use thiroedoxin-
tagged dHax3.N protein purified from bacteria for digestion analysis. First, to 
linearize pCRII/EBE clones, we cut the pCRII/EBE clones at a unique restriction 
site for NcoI or XcmI. Further, the plasmid is gel-purified and used as a substrate 
to test dHax3.N cleavage ability. In our digestion analysis, we used various 
buffers, incubated together with purified dHax3.N protein and linearized 
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pCRII/EBE clones, with 30 minutes incubation time at 37° C. We did not observe 
any cleavage activity when using the EMSA DNA-binding buffer (12 mM 
Tris·HCL, 60 mM KCl, 2.5% glycerol, 5 mM MgCl2), whereas when using (20 mM 
Tris·acetate, 50 mM potassium acetate, 10 mM magnesium acetate, 1 mM DTT, 
pH 7.9) we only observed slight cleavage activity. Cleavage activity of dHax3.N is 
highest observed when we used the reaction buffer containing 20 mM Tris·HCl 
(pH 7.4), 5 mM MgCl2, 50 mM KCl, 5% glycerol, and 0.5 mg/mL BSA, where 
dHax3.N cut linearized pCRII/EBE plasmid into two fragments of the expected 
size (1.6 and 2.4 kb).  
 
In this experiment we used clones with various spacer lengths between dHax3.N 
binding sites to identify the most optimal spacer lengths to support FokI 
dimerization and nuclease activity. We observed that dHax3.N does not show 
cleavage activity when incubated with EBE clone with a 6-bp spacer-length clone 
(pCRII/EBE6) while a little cleavage activity was observed when incubated with 
EBE clone with a 10-bp spacer-length (pCRII/EBE10). Robust and highest 
cleavage activity was observed when dHax3.N was incubated with EBE clone 
with a 16-bp spacer-length (pCRII / EBE16), in which we observed that the 
pCRII/ EBE16 was cut into an expected cleavage pattern (Fig. 5C). Our results 
correspond to several other reports which mention that the length of spacer 
region is important for TALE Nuclease cleavage activity. 
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Fig. 5. In vitro DNA digestion by dHax3.N Hybrid Nuclease (A) dHax3.N DNA 
target sequence, EBE sequences in tail-to-tail orientation are shown in blue, and 
the 6-bp, 10-bp and 16-bp spacer sequences are shown in red. (B) Circular 
plasmid of pCRII-TOPO containing two EBE target sequence in a tail-to-tail 
orientation with predicted cleavage sites for SmaI and NcoI enzymes. (C) Activity 
of dHax3.N Hybrid Nuclease on DNA targets with different spacer lengths. In all 
panels, M refers to 1-kb Marker, lane 1 is undigested plasmid. Lane 2 is NcoI-
linearized plasmid. Lane 3 is plasmid digested with NcoI and SmaI. Lane 4 is 
NcoI-linearized plasmid digested with dHax3.N for 30 min at 37 °C. Lane 4 in 
panel EBE6 did not showed the expected cleavage products, indicating that 
dHax3.N was unable to bind and cut the target sequence with 6-bp spacer 
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between the two EBEs. Lane 4 in the EBE10 panel showed a little cleavage 
activity of dHax3.N. Lane 4 of panel EBE16 showed a significant cleavage 
activity of dHax3.N, where the expected cleavage products can be seen clearly. 
Lane 4 of panel EBE16 T/A showed very little cleavage activity of dHax3.N, 
indicating the specificity of dHax3.N. While in the In lane 4 of EBE16ΔT0, where 
the T nucleotide at the repeat 0 had been removed, there were no cleavage 
activity of dHax3.N, indicating that the nucleotide T at repeat 0 played an 
important role in the cleavage activity of dHax3.N. (D) The effect of incubation 
time on cleavage activity of dHax3.N. (E) The effect of various incubation 
temperatures on the cleavage activity of dHax3.N (M refers to 1-kb Marker, U 
refers to unlinearized plasmid, NcoI refers to NcoI-linearized plasmid). 
 
Next we would like to study the binding specificity of dHax3.N in greater detail as 
well as the effects of mutations on EBE sequence to TALE Nuclease binding and 
cleavage activity. For that we deleted the nucleotide T at the repeat 0 or replaced 
T with A in repeat 12 (henceforth these two constructs are called 
pCRII/EBE16ΔT0 and EBE16T/A, respectively). We observed that nucleotide T 
deletion in repeat 0 significantly reduced cleavage activity of dHax3.N (Fig. 5C). 
We also observed that the substitution of T with A at repeat 12 also reduced the 
cleavage activity of dHax3.N significantly (Fig. 5C). Our results may indicate that 
the T nucleotide in repeat 0 plays an important role for TALE binding to their 
target DNA sequence. It also demonstrated that dHax3.N is a very specific 
endonuclease, in which changes in one nucleotide only in the sequence of the 
target DNA can inhibit the binding and cleavage activity of dHax3.N significantly. 
 
Furthermore, we also performed cleavage analysis of dHax3.N with varied 
incubation time and at various temperatures. In general, we observed that the 
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cleavage products increased with the addition of incubation time (Fig. 5D). For 
incubation at different temperatures (0° C to 55), our data indicate that the 
cleavage activity of dHax3.N is most optimal when the digestion reaction was 
incubated at 23° C and 37° C. Outside this range, the dHax3.N cleavage activity 
decreased significantly (Fig. 5E). To determine the cleavage sites of dHax3.N, 
we purified 1.620- and 2.424-bp DNA fragment generated from the cutting of 
dHax3.N in pCRII/EBE clones for sequencing. The data we obtained confirmed 
that dHax3.N cut pCRII/EBE clones in the spacer region (Appendix 3). 
 
dHax3.N Hybrid Nuclease Creates DSB in vivo in tobacco Transient 
Assays.  
We have demonstrated the ability of dHax3.N to attach and cut DNA in specific 
target sequences in vitro. Further, we would like to study the activity of dHax3.N 
in vivo in plant cells, for that we adapted a modified A. tumefaciens mediated 
tobacco transient assay (Zhang et al., 2010). We constructed two EBE target 
sequences in a tail-to-tail orientation separated by spacers with the length of 16-
bp. A TGA stop codon was inserted in the spacer region and we also inserted an 
ATG start codon in front of the forward EBE sequence. The 
ATG.EBE.TGA.spacer.EBE construct was then combined with the GUS-reporter 
gene (uidA coding sequence) (Fig. 6A). The ATG.EBE.TGA.spacer. EBE::uidA 
was generated through PCR amplification, and then cloned into pENTR/D vector 
which then subcloned into pK2GW7 overexpression vector. We hypothesize that 
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when the construct was introduced and expressed in plant cells, the TGA stop 
codon would prematurely stop the uidA reporter gene expression.  
 
Fig. 6. dHax3.N Hybrid Nuclease induces DSB in vivo. (A) dHax3.N EBE target 
sequence in a tail-to-tail orientation with a TGA stop codon in the spacer region 
and a ATG start codon preceding the EBE forward sequence (B) dHax3.N 
activity in tobacco transient expression assays. Panels 1 and 2 showed no UidA 
activity in leaves infiltrated with 35S::EBE.TGA.spacer.EBE.uidA or 35S::dHax3, 
respectively. Panel 3 displayed uidA activity in leaves infiltrated with 
35S::EBE.TGA.spacer.EBE.uidA along with 35S::dHax3.N. Panel 4 showed 
strong uidA activity in leaves infiltrated with 35S::uidA (positive control). 
 
We reasoned that if dHax3.N is expressed and active in plant cells, this protein 
will cut ATG.EBE.TGA.spacer.EBE::uidA construct in the spacer region and 
create a DSB. In plant cells, DSBs will be repaired by one of two cellular repair 
pathways, namely non-homologous end joining (NHEJ) and homologous 
recombination (HR). NHEJ repair joins the ends of broken strands and results in 
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small deletions or insertions, which may lead to the elimination of the TGA stop 
codon and the expression of the uidA reporter. To test this hypothesis, we co-
infiltrated or infiltrated separately A. tumefaciens carrying 
35S::ATG.EBE.TGA.spacer.EBE::uidA, 35S::uidA, 35S::dHax3, and 
35S::dHax3.N on N. benthamiana leaves.  
 
In accordance with the hypothesis, as shown by GUS staining assay, leaves 
infiltrated with 35S::ATG.EBE.TGA.spacer.EBE::uidA, 35S::uidA construct 
showed no UidA reporter activity. UidA reporter activity was also not detected in 
leaves that are co-infiltrated with 35S::ATG.EBE.TGA.spacer.EBE::uidA and 
35S::dHax3 constructs. However, when 35S::ATG.EBE.TGA.spacer.EBE::uidA 
construct was infiltrated along with 35S::dHax3.N construct, uidA activity is 
apparent (Fig. 6B). Our results may indicate that the 35S::dHax3.N is expressed 
and active in plant cells, and able to induce the DSB at the spacer region of 
35S::ATG.EBE.TGA.spacer.EBE::uidA construct. Subsequently, the generated 
DSB was then repaired by cellular repairing machinery which leads to the 
elimination of TGA stop codon in the spacer region of 
35S::ATG.EBE.TGA.spacer.EBE::uidA construct.. As a positive control, 
35S::uidA was infiltrated into leaves, where we observed that uidA was clearly 
expressed (Fig. 4B). Overall, our data demonstrated the TALE-based hybrid 
nuclease ability to bind to its target and create DSB in vivo when transiently 
expressed in N. benthamiana leaves.  
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IV. DISCUSSION  
In this study, we demonstrated the construction of novel TALE hybrid nuclease 
capable of binding and cutting user pre-defined target sequences, both in vitro 
and in vivo. We used Hax3 TALE as the basis for constructing novel hybrid 
nuclease by combining the DNA binding region of Hax3 with a non-specific 
cleavage domain from the type II restriction endonuclease FokI. We chose Hax3 
TALE protein as a template, because this protein has a relatively smaller size 
than other members of TALEs protein family, but have a long enough central 
number tandem repeat to recognize and activate specific target DNA sequences 
(Boch et al., 2009). We showed that our de novo engineered dHax3 and 
dHax3.N were able to recognize and attach to EBE target sequences in vitro, as 
shown in the results of EMSA. We also showed the ability of our de novo 
engineered dHax3 and dHax3.N to attach and activate the transcription of the 
target gene in vivo, as shown in the tobacco transient expression assays. It is to 
be noted that the combination of the FokI nuclease domain does not affect the 
binding specificity of Hax3 TALE as well as the activity of its C-terminal 
transcription activation domain. 
 
FokI monomers must form a dimer in order to cut the DNA sequences. In ZFNs, 
two ZFN constructs was designed to be able to identify two target sequences in a 
tail-to-tail orientation separated by a spacer sequence. When ZFN was attached 
to the target sequence, the FokI can form a dimer and cut the DNA in the spacer 
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region (Carroll, 2008; Vanamee et al., 2001). Several previous studies have 
reported that the length of linker between DNA binding modules and nuclease 
domain, and the spacer length between target sequences significantly influence 
the cleavage activity of ZFNs. ZFN with a shorter length of linker was found to be 
able to cut a target with a shorter length of spacer (Bibikova et al., 2001). ZFNs 
with linker length from 4 to 18-aa showed the highest cleavage activity on the 
target with the spacer length of 5 to 8-bp (Händel et al., 2008). The length of 
spacer between the two EBE target sequences necessary for our engineered 
dHax3.N to show optimal cleavage activity is still not clear.  
 
To test the nuclease activity of dHax3.N and to determine the length of spacer 
sequence that enables the most efficient dHax3.N cut, we constructed a target 
site with two EBE target sequences in a tail-to-tail orientation separated by 
spacers with different lengths. In vitro digestion analysis showed that dHax3.N 
had the highest cleavage activity on the target with 16-bp spacer. The TALE 
hybrid nuclease that we constructed had a 286-aa long linker between the DNA 
binding domain and the nuclease domain. The length of the linker in the protein 
we constructed is likely to be the cause of why our protein had the highest 
cleavage activity on 16-bp long targets, instead of on targets with 10-bp or 6-bp 
spacer length. If necessary, we believe it is possible to construct a novel TALE 
hybrid nuclease capable of recognizing targets with a shorter spacer length by 
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designing a TALE hybrid nuclease that has a shorter linker between the DNA 
binding domain and the nuclease domain. 
 
After demonstrating that dHax3.N was able to cut target sequences with the 
appropriate length of spacer, we further showed the significance of nucleotide T 
at repeat 0 of the target sequence in the binding and nuclease activity of TALE 
hybrid nuclease. The removal of nucleotide T at repeat 0 on the target sequence 
as found in the construct pCRII/EBE16ΔT drastically reduced the cleavage 
activity of dHax3.N. Additionally, we also showed the specificity of dHax3.N, in 
which we demonstrated that the replacement of nucleotide T with A at repeat 12 
of the target sequence also reduced the cleavage activity of dHax3.N.  
 
Further, we demonstrated the ability of dHax3.N to induce DSB in the target DNA 
in vivo in tobacco transient expression assays. Our data indicate that dHax3.N 
induced DSB in the spacer region of the target DNA, which was subsequently 
repaired by the NHEJ repair machinery. DSB repair via the NHEJ pathway 
caused a small deletion and the elimination of the TGA stop codon at 
ATG.EBE.TGA.spacer.EBE::uidA constructs, subsequently induced the 
activation of uidA reporter gene.  
 
40 
 
The data we obtained showed that TALE hybrid nuclease can be expressed and 
is active in plant cells; these findings demonstrate the great potential of TALE 
hybrid nuclease to be used in genome engineering. So far, meganucleases and 
ZFNs have been widely used to induce site-specific DSBs in the genome of 
various organisms, but meganucleases and ZFNs technology lack flexibility, 
adaptability, and reproducibility to be used routinely in genome engineering 
(Miller et al., 2010; Ramirez et al., 2008). The DNA binding domain of TALEs has 
clearly predictable sequence specificity, while the specificity of a ZFN designed 
to recognize a specific target must be identified laboriously from complex 
expression libraries. Additionally TALEs can be designed to target long DNA 
target sequences and the modular nature of TALE’s tandem-arranged repeats 
allows rapid construction of novel TALEs with user pre-defined specificity. The 
data we obtained along with the data published by Li et al. (Li et al., 2010; Li et 
al., 2011), Christian et al. (Christian et al., 2010), Cermak et al. (Cermak et al., 
2011), and Miller et al. (Miller et al., 2010) indicate that the DNA binding modules 
of TALE has the flexibility and adaptability to be used in genome engineering in a 
simple, reproducible and efficient manner. 
 
In the future, TALE hybrid nuclease can be applied for the purposes of gene 
disruptions, corrections, and additions. The DNA binding specificity of native or 
artificial TALE that highly predictable, suggests a variety of applications of this 
protein. The DNA binding domain of TALEs can be combined with various 
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functional domains, such as nucleases, methylases, recombinases, or 
transcription-repressor domains. Several strategies could be applied to mediate 
TALE hybrid nuclease delivery and expression in plant cells. TALE hybrid 
nuclease can be transfected into protoplast via chemical transformation or into 
embryonic culture via gene gun bombardment and chemical transformation. 
Transformation with Agrobacterium or virus-aided gene expression (VAGE) also 
can be use to introduced TALE hybrid nucleases into the plants cells (Fig. 7).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7. Strategies for TALE hybrid nucleases delivery and expression in plant 
cells.  
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In human cell cultures, Miller et al. reported that the efficiency of TALENs in 
modifying genome target equals that of various ZFNs (Miller et al., 2010). TALEs 
are still in the initial stage of development and in the future its efficiency can still 
be increased significantly. Coupled with the simple recognition code of TALE and 
the modular nature of the TALE DNA recognition code, TALE hold much promise 
as precise gene editing tools. However, it should be mentioned that there are 
many unknown details about the nature of binding and the effect of the repeat 
length and the neighboring repeats. In ZFNs, the interaction between one zinc 
finger and other zinc fingers as well as the amount of zinc fingers in zinc finger 
arrays were found to affect the DNA binding activity of zinc finger arrays (Isalan 
et al., 1997). It should be investigated whether the interaction between the repeat 
domains in TALE tandem-repeats array and the number of repeats may also 
affect the DNA binding activity and specificity of TALEs. Additionally, 
computational studies on positional bias for nucleotides have suggested that 
there is a strong bias against nucleotides T, A and G at positions 1, 2 and 3 
respectively. There is a moderate bias for T in the last half repeat. Consequently 
there is a corresponding RVD bias: NG and NI are disfavored in repeat 1 and 2 
and NN is disfavored in the last half repeat. Several reports have demonstrated a 
variability of TALEs-mediated transcriptional activation, which might be related to 
the nature of binding. It should be noted that structural studies on the nature and 
parameters of TALE-DNA binding is required for effective and efficient design. 
Finally, in the future it needs to be proven whether the TALE hybrid nuclease can 
attach to and induce DSB at chromosomal locus. We are currently conducting 
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experiments to test whether engineered TALE-based hybrid nuclease can 
recognize and cleave endogenous chromosomal targets. These experiments will 
be keys to evaluating the application of TALE-based hybrid nuclease for genome 
engineering in plants and eukaryotes in general. Engineered TALE may 
significantly advance the genome modification technologies and be a powerful 
tool for agricultural biotechnology or gene therapy. 
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APPENDICES 
 
Appendix 1. dHax3 and dHax3.N Sequence 
dHax3 Sequence 
ATGGACCCAATACGAAGCAGAACGCCATCACCAGCTAGGGAACTTCTCTCTGGACCACA
GCCTGATGGAGTTCAGCCAACTGCAGATCGAGGTGTTTCTCCGCCAGCCGGTGGCCCTT
TAGATGGTCTCCCAGCAAGAAGAACAATGTCCCGTACCAGACTCCCAAGTCCCCCTGCC
CCGTCGCCAGCCTTTTCAGCTGACTCCTTCTCTGATCTTCTTAGGCAATTTGACCCTTC
TCTTTTCAATACATCCCTTTTCGATTCACTTCCTCCTTTCGGCGCACATCATACTGAGG
CAGCCACCGGCGAATGGGACGAAGTCCAAAGTGGTTTAAGGGCAGCTGATGCTCCACCA
CCGACGATGAGAGTCGCTGTTACCGCCGCACGTCCTCCTAGAGCCAAGCCAGCCCCTAG
AAGACGAGCTGCGCAACCCTCCGATGCAAGCCCTGCAGCTCAAGTAGACCTTCGAACAC
TAGGTTACTCCCAGCAACAACAAGAAAAAATAAAGCCAAAGGTTAGATCTACAGTTGCA
CAACATCACGAAGCCCTAGTCGGACACGGATTTACACATGCTCATATCGTGGCTCTTTC
ACAACATCCTGCAGCTCTTGGAACAGTCGCTGTCAAATATCAGGATATGATTGCTGCAT
TGCCAGAAGCTACTCACGAAGCTATCGTCGGAGTTGGGAAACAATGGTCAGGCGCAAGA
GCATTAGAGGCGCTTCTCACCGTAGCTGGTGAATTACGAGGTCCTCCACTCCAATTGGA
TACTGGGCAATTATTAAAAATCGCTAAACGAGGTGGAGTCACTGCTGTCGAAGCCGTTC
ATGCATGGCGTAACGCTCTCACGGGCGCACCACTAAACCTTACTCCTGAACAGGTTGTC
GCAATAGCTTCACATGATGGCGGAAAACAAGCTCTTGAAACAGTGCAACGTCTCCTTCC
CGTCCTCTGTCAGGCTCACGGATTGACTCCTCAGCAGGTCGTCGCAATTGCATCACATG
ATGGAGGCAAACAAGCTTTAGAAACAGTACAAAGACTATTGCCCGTTCTTTGCCAAGCG
CATGGGTTAACTCCCGAACAAGTCGTTGCCATTGCAAGTCACGACGGAGGTAAACAAGC
TCTCGAAACGGTTCAAGCACTTTTACCCGTTCTCTGTCAAGCACATGGACTCACACCTG
AACAAGTAGTTGCTATCGCATCGAATGGAGGTGGAAAACAAGCACTGGAAACTGTACAA
AGACTTTTGCCAGTTTTATGTCAAGCGCACGGTCTTACTCCTCAACAAGTTGTCGCCAT
TGCCTCTAACGGTGGTGGAAAACAAGCTCTTGAAACTGTCCAGAGACTTCTGCCCGTTC
TATGTCAGGCTCATGGGCTAACCCCTCAACAGGTTGTTGCAATCGCATCTAATGGAGGA
GGAAAACAAGCTTTAGAAACTGTCCAACGACTACTGCCCGTTCTCTGCCAAGCACACGG
ACTTACCCCACAACAAGTTGTGGCAATAGCTTCTAATTCTGGTGGTAAACAAGCCCTTG
AGACGGTTCAAAGACTTCTACCAGTTCTTTGTCAGGCACATGGATTGACCCCACAACAG
GTCGTAGCAATCGCATCTAATGGAGGTGGTAAGCAAGCTCTAGAAACGGTACAAAGATT
ACTTCCCGTGCTTTGTCAAGCTCATGGACTCACTCCTCAACAAGTGGTCGCTATTGCAA
GTCATGATGGTGGAAAGCAAGCACTAGAAACCGTCCAACGACTCCTTCCTGTTCTCTGT
CAAGCACATGGTCTTACGCCCGAACAAGTTGTTGCTATAGCTTCGAACGGAGGTGGAAA
ACAAGCTCTCGAAACCGTCCAAAGGCTCCTCCCAGTACTTTGCCAAGCACATGGATTAA
CCCCTGAGCAAGTAGTTGCAATTGCCTCGCACGACGGAGGAAAGCAAGCATTAGAAACT
GTTCAGAGACTTTTGCCTGTCCTGTGTCAAGCCCACGGTCTAACACCACAACAAGTCGT
CGCAATCGCTAGTAATGGAGGAGGTAGACCTGCATTGGAGTCGATAGTCGCACAACTAT
CACGACCTGATCCCGCTCTTGCAGCATTGACAAACGATCATTTAGTCGCACTTGCATGT
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TTAGGAGGACGACCAGCACTTGATGCCGTTAAGAAAGGACTACCGCACGCCCCTGCATT
GATTAAAAGAACAAACAGACGAATCCCGGAGAGAACTTCACATCGTGTAGCCGATCATG
CTCAAGTCGTAAGAGTTTTGGGTTTCTTCCAATGTCATTCCCACCCAGCTCAAGCTTTT
GACGATGCAATGACTCAATTTGGAATGAGTAGACATGGACTCCTGCAATTATTTCGAAG
GGTCGGAGTTACAGAGCTCGAAGCCAGGTCAGGAACGCTGCCCCCCGCATCTCAACGAT
GGGATAGAATTCTCCAAGCCTCTGGAATGAAAAGAGCTAAACCTTCACCAACGTCCACA
CAAACACCAGACCAAGCTTCTCTCCACGCTTTTGCCGACTCACTAGAGAGAGATCTAGA
TGCACCGTCACCTATGCATGAAGGAGACCAAACAAGAGCCTCTTCAAGAAAACGTTCTC
GTTCTGATAGAGCTGTCACTGGACCTTCCGCCCAACAATCTTTCGAAGTCCGAGTTCCT
GAGCAACGAGATGCCCTACACCTGCCTTTGCTTTCTTGGGGAGTTAAGCGACCACGTAC
TAGAATTGGTGGACTACTCGATCCAGGTACACCAATGGATGCTGATCTCGTTGCTTCCT
CTACCGTAGTATGGGAGCAAGACGCAGACCCCTTCGCTGGAACTGCTGACGATTTCCCA
GCCTTTAACGAGGAAGAATTGGCTTGGTTAATGGAACTTCTACCGCAATGA 
 
 
dHax3.N sequence 
 
ATGGACCCAATACGAAGCAGAACGCCATCACCAGCTAGGGAACTTCTCTCTGGACCACA
GCCTGATGGAGTTCAGCCAACTGCAGATCGAGGTGTTTCTCCGCCAGCCGGTGGCCCTT
TAGATGGTCTCCCAGCAAGAAGAACAATGTCCCGTACCAGACTCCCAAGTCCCCCTGCC
CCGTCGCCAGCCTTTTCAGCTGACTCCTTCTCTGATCTTCTTAGGCAATTTGACCCTTC
TCTTTTCAATACATCCCTTTTCGATTCACTTCCTCCTTTCGGCGCACATCATACTGAGG
CAGCCACCGGCGAATGGGACGAAGTCCAAAGTGGTTTAAGGGCAGCTGATGCTCCACCA
CCGACGATGAGAGTCGCTGTTACCGCCGCACGTCCTCCTAGAGCCAAGCCAGCCCCTAG
AAGACGAGCTGCGCAACCCTCCGATGCAAGCCCTGCAGCTCAAGTAGACCTTCGAACAC
TAGGTTACTCCCAGCAACAACAAGAAAAAATAAAGCCAAAGGTTAGATCTACAGTTGCA
CAACATCACGAAGCCCTAGTCGGACACGGATTTACACATGCTCATATCGTGGCTCTTTC
ACAACATCCTGCAGCTCTTGGAACAGTCGCTGTCAAATATCAGGATATGATTGCTGCAT
TGCCAGAAGCTACTCACGAAGCTATCGTCGGAGTTGGGAAACAATGGTCAGGCGCAAGA
GCATTAGAGGCGCTTCTCACCGTAGCTGGTGAATTACGAGGTCCTCCACTCCAATTGGA
TACTGGGCAATTATTAAAAATCGCTAAACGAGGTGGAGTCACTGCTGTCGAAGCCGTTC
ATGCATGGCGTAACGCTCTCACGGGCGCACCACTAAACCTTACTCCTGAACAGGTTGTC
GCAATAGCTTCACATGATGGCGGAAAACAAGCTCTTGAAACAGTGCAACGTCTCCTTCC
CGTCCTCTGTCAGGCTCACGGATTGACTCCTCAGCAGGTCGTCGCAATTGCATCACATG
ATGGAGGCAAACAAGCTTTAGAAACAGTACAAAGACTATTGCCCGTTCTTTGCCAAGCG
CATGGGTTAACTCCCGAACAAGTCGTTGCCATTGCAAGTCACGACGGAGGTAAACAAGC
TCTCGAAACGGTTCAAGCACTTTTACCCGTTCTCTGTCAAGCACATGGACTCACACCTG
AACAAGTAGTTGCTATCGCATCGAATGGAGGTGGAAAACAAGCACTGGAAACTGTACAA
AGACTTTTGCCAGTTTTATGTCAAGCGCACGGTCTTACTCCTCAACAAGTTGTCGCCAT
TGCCTCTAACGGTGGTGGAAAACAAGCTCTTGAAACTGTCCAGAGACTTCTGCCCGTTC
TATGTCAGGCTCATGGGCTAACCCCTCAACAGGTTGTTGCAATCGCATCTAATGGAGGA
GGAAAACAAGCTTTAGAAACTGTCCAACGACTACTGCCCGTTCTCTGCCAAGCACACGG
ACTTACCCCACAACAAGTTGTGGCAATAGCTTCTAATTCTGGTGGTAAACAAGCCCTTG
AGACGGTTCAAAGACTTCTACCAGTTCTTTGTCAGGCACATGGATTGACCCCACAACAG
GTCGTAGCAATCGCATCTAATGGAGGTGGTAAGCAAGCTCTAGAAACGGTACAAAGATT
ACTTCCCGTGCTTTGTCAAGCTCATGGACTCACTCCTCAACAAGTGGTCGCTATTGCAA
52 
 
GTCATGATGGTGGAAAGCAAGCACTAGAAACCGTCCAACGACTCCTTCCTGTTCTCTGT
CAAGCACATGGTCTTACGCCCGAACAAGTTGTTGCTATAGCTTCGAACGGAGGTGGAAA
ACAAGCTCTCGAAACCGTCCAAAGGCTCCTCCCAGTACTTTGCCAAGCACATGGATTAA
CCCCTGAGCAAGTAGTTGCAATTGCCTCGCACGACGGAGGAAAGCAAGCATTAGAAACT
GTTCAGAGACTTTTGCCTGTCCTGTGTCAAGCCCACGGTCTAACACCACAACAAGTCGT
CGCAATCGCTAGTAATGGAGGAGGTAGACCTGCATTGGAGTCGATAGTCGCACAACTAT
CACGACCTGATCCCGCTCTTGCAGCATTGACAAACGATCATTTAGTCGCACTTGCATGT
TTAGGAGGACGACCAGCACTTGATGCCGTTAAGAAAGGACTACCGCACGCCCCTGCATT
GATTAAAAGAACAAACAGACGAATCCCGGAGAGAACTTCACATCGTGTAGCCGATCATG
CTCAAGTCGTAAGAGTTTTGGGTTTCTTCCAATGTCATTCCCACCCAGCTCAAGCTTTT
GACGATGCAATGACTCAATTTGGAATGAGTAGACATGGACTCCTGCAATTATTTCGAAG
GGTCGGAGTTACAGAGCTCGAAGCCAGGTCAGGAACGCTGCCCCCCGCATCTCAACGAT
GGGATAGAATTCTCCAAGCCTCTGGAATGAAAAGAGCTAAACCTTCACCAACGTCCACA
CAAACACCAGACCAAGCTTCTCTCCACGCTTTTGCCGACTCACTAGAGAGAGATCTAGA
TGCACCGTCACCTATGCATGAAGGAGACCAAACAAGAGCCTCTTCAAGAAAACGTTCTC
GTTCTGATAGAGCTGTCACTGGACCTTCCGCCCAACAATCTTTCGAAGTCCGAGTTCCT
GAGCAACGAGATGCCCTACACCTGCCTTTGCTTTCTTGGGGAGTTAAGCGACCACGTAC
TAGAATTGGTGGACTACTCGATCCAGGTACACCAATGGATGCTGATCTCGTTGCTTCCT
CTACCGTAGTATGGGAGCAAGACGCAGACCCCTTCGCTGGAACTGCTGACGATTTCCCA
GCCTTTAACGAGGAAGAATTGGCTTGGTTAATGGAACTTCTACCGCAAAAGCAACTAGT
CAAAAGTGAACTGGAGGAGAAGAAATCTGAACTTCGTCATAAATTGAAATATGTGCCTC
ATGAATATATTGAATTAATTGAAATTGCCAGAAATTCCACTCAGGATAGAATTCTTGAA
ATGAAGGTAATGGAATTTTTTATGAAAGTTTATGGATATAGAGGTAAACATTTGGGTGG
ATCAAGGAAACCGGACGGAGCAATTTATACTGTCGGATCTCCTATTGATTACGGTGTGA
TCGTGGATACTAAAGCTTATAGCGGAGGTTATAATCTGCCAATTGGCCAAGCAGATGAA
ATGCAACGATATGTCGAAGAAAATCAAACACGAAACAAACATATCAACCCTAATGAATG
GTGGAAAGTCTATCCATCTTCTGTAACGGAATTTAAGTTTTTATTTGTGAGTGGTCACT
TTAAAGGAAACTACAAAGCTCAGCTTACACGATTAAATCATATCACTAATTGTAATGGA
GCTGTTCTTAGTGTAGAAGAGCTTTTAATTGGTGGAGAAATGATTAAAGCCGGCACATT
AACCTTAGAGGAAGTGAGACGGAAATTTAATAACGGCGAGATAAACTTTTGA 
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Appendix 2. TRX.dHax3 and TRX.dHax3.N proteins migrate to their expected 
sizes on SDS gel electrophoresis. M, protein marker; U, uninduced fraction; I, 
induced fraction (IPTG was used as the inducer); P, purified protein. 
 
 
 
 
 
 
 
 
 
Appendix 3. DNA sequencing of cleavage products confirm cleavage sites within 
the spacer regio 
 
 
 
 
 
 
 
 
 
 
